Magnesium Sulfate Effect Following the Reversal of Neuromuscular Blockade Induced by Rocuronium With Sugammadex

• Status: Completed
• Trial end date: 2017-03-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of this study is to evaluate the treatment effect of magnesium sulfate on the T4 / T1 ratio after reversal with sugammadex deep or moderate neuromuscular blockade induced by rocuronium.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Universidade Federal do Rio de Janeiro
• Treatments: Magnesium Sulfate; Pharmaceutical Solutions; Rocuronium

Criteria

Inclusion Criteria:

• ASA physical status 1 or 2

• weight BMI 18.5-24.9

• otorhinolaryngological surgeries

Exclusion Criteria:

• refusal to participate in the study;

• pregnancy or suspected pregnancy;

• neuromuscular diseases, renal or hepatic impairment;

• hepatic dysfunction;

• story or predictors of difficult airway;

• hypermagnesemia (Mg> 2.5 mEq / L);

• hypomagnesemia (Mg <1.7 mEq / L);

• furosemide, aminoglycosides, aminophylline azathioprine; cyclophosphamide, anti-inflammatory and magnesium;

• allergy to drugs used in the study;

• participants from other clinical studies.